Loading...
XKRX044820
Market cap55mUSD
Jan 10, Last price  
8,530.00KRW
1D
0.35%
1Q
-2.85%
Jan 2017
-77.19%
IPO
108.06%
Name

Cosmax BTI Inc

Chart & Performance

D1W1MN
XKRX:044820 chart
P/E
8.99
P/S
0.13
EPS
948.36
Div Yield, %
0.00%
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
7.48%
Revenues
628.60b
+1.81%
82,538,385,000114,546,398,000154,217,118,000192,451,188,000244,001,150,250312,552,367,360379,008,424,320135,906,970,700199,869,310,100266,924,996,310298,287,327,230438,275,251,190468,352,868,370525,904,306,470575,998,201,640617,403,775,020628,597,019,220
Net income
9.06b
P
-1,681,352,0001,556,924,0009,797,404,0008,851,237,00011,508,716,00020,485,675,00021,928,037,00013,554,745,0508,002,588,00015,356,047,4303,844,182,7109,503,200,350-13,904,654,340-17,174,579,6104,343,190,420-20,235,925,0709,061,400,050
CFO
29.78b
-0.58%
-4,352,108,00011,850,649,0004,367,305,0003,510,352,00016,792,897,99011,545,222,65013,461,263,2406,052,425,05023,905,379,41012,759,533,88010,890,467,690-1,358,392,340-5,674,823,56041,467,271,480-22,348,15029,958,706,17029,784,900,243
Dividend
Dec 27, 2023350 KRW/sh
Earnings
Mar 05, 2025

Profile

Cosmax BTI, Inc. engages in the development, production, and supply of beauty products, health functional foods, pharmaceuticals, and special containers and equipment for customers in South Korea. The company offers sun and foundation creams; makeup creams and bases; hair and cleansing products; mascara and nail products; various color formulations and skin tones; lip sticks and shadows; lip essence and liquid products; body and mask sheets; powder pact products and makeup pencils; and fragrance products. It exports its products to approximately 30 countries. The company was founded in 1992 and is headquartered in Seongnam, South Korea.
URL
http://www.cosmaxbti.com/
IPO date
Nov 13, 2006
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
628,597,019
1.81%
617,403,775
7.19%
Cost of revenue
555,655,290
561,482,986
Unusual Expense (Income)
NOPBT
72,941,729
55,920,789
NOPBT Margin
11.60%
9.06%
Operating Taxes
8,329,692
12,255,271
Tax Rate
11.42%
21.92%
NOPAT
64,612,037
43,665,518
Net income
9,061,400
-144.78%
(20,235,925)
-565.92%
Dividends
(2,484,258)
Dividend yield
2.93%
Proceeds from repurchase of equity
(522,087)
BB yield
0.51%
Debt
Debt current
441,607,587
337,934,131
Long-term debt
28,732,355
133,071,591
Deferred revenue
200,000
200,000
Other long-term liabilities
41,131,620
30,043,194
Net debt
72,839,437
4,501,177
Cash flow
Cash from operating activities
29,784,900
29,958,706
CAPEX
(27,715,813)
(13,741,577)
Cash from investing activities
(39,013,625)
544,385
Cash from financing activities
(7,669,102)
(23,547,379)
FCF
62,297,404
68,869,149
Balance
Cash
78,705,028
95,464,539
Long term investments
318,795,477
371,040,006
Excess cash
366,070,654
435,634,356
Stockholders' equity
123,355,664
124,046,328
Invested Capital
633,308,260
691,679,796
ROIC
9.75%
6.28%
ROCE
9.61%
6.83%
EV
Common stock shares outstanding
9,555
9,555
Price
10,630.00
19.84%
8,870.00
-34.78%
Market cap
101,567,939
19.84%
84,751,422
-37.95%
EV
194,976,708
119,584,692
EBITDA
99,266,491
84,322,738
EV/EBITDA
1.96
1.42
Interest
24,777,083
17,697,848
Interest/NOPBT
33.97%
31.65%